v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development $ 176,065 $ 200,927
General and administrative 60,091 62,537
Acquired in-process research and development 5,000 0
Total operating expenses 241,156 263,464
Loss from operations (241,156) (263,464)
Other income (expense):    
Interest income 8,344 19,933
Interest expense (3,219) 0
Other expense, net (767) (78)
Total other income 4,358 19,855
Net loss before income taxes (236,798) (243,609)
Provision for income taxes 130 178
Net loss (236,928) (243,787)
Other comprehensive loss:    
Unrealized gain (loss) on marketable securities (62) 138
Comprehensive loss $ (236,990) $ (243,649)
Net loss per share, basic $ (1.45) $ (1.53)
Net loss per share, diluted $ (1.45) $ (1.53)
Weighted-average shares outstanding, basic 163,391 159,377
Weighted-average shares outstanding, diluted 163,391 159,377